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Abstract 
Exposure of the JAR human placental choriocarcinoma cells to taurine leads to a marked decrease in the activity of the taurine 
transporter in these cells. The ability to induce this adaptive response is not unique to taurine but is shared by other substrates of the 
transporter as well. Compounds such as betaine and a-aminoisobutyric a id which are not substrates for the transporter do not produce 
this effect. The change in the taurine transporter activity induced by taurine exposure is however unique to the taurine transporter because 
the activities of many other transport systems remain unaffected under these conditions. The adaptive regulation is not associated with any 
change in the dependence of the transporter activity on Na + and CI-, in the Na÷/C1-/taurine stoichiometry and in the affinities of the 
transporter for Na + and C1-. The decrease in the transporter activity caused by taurine exposure is due to a decrease in the maximal 
velocity of the transporter, and to a lesser extent, in the substrate affinity of the transporter. The decrease in the transporter activity 
observed in intact cells is demonstrable in plasma membrane vesicles after isolation from control and taurine-exposed cells. Cyclohex- 
imide and actinomycin D block the adaptive response in intact cells to a significant extent, but not completely. Northern blot analysis of 
mRNA from control and taurine-exposed cells shows that taurine exposure causes a significant decrease in the steady state levels of the 
taurine transporter mRNA. It is concluded that the activity of the taurine transporter in JAR cells is subject o substrate-specific adaptive 
regulation and that transcriptional s well as posttranscriptional events are involved in this regulatory process. 
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1. Introduction 
Human placenta expresses an active transport system 
for taurine and other/3-amino acids in the maternal-facing 
brush border membrane [1,2]. This taurine transporter has 
been recently cloned and characterized [3]. The transporter 
is believed to be obligatorily involved in the transplacental 
transfer of taurine from mother to fetus. Since the human 
fetus has no ability to synthesize taurine endogenously and 
yet is known to accumulate very high levels of this amino 
acid in tissues, the function of the transporter assumes 
great importance as being the sole mechanism available for 
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* Corresponding author. Fax: + 1 (706) 7216608. 
0005-2736/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2736(95)00006-2 
the fetus to meet its taurine requirements. The JAR human 
placental choriocarcinoma cell line which has been shown 
to express the taurine transporter [4] has proved to be very 
useful in the investigation of the regulatory aspects of the 
transporter. The function of the transporter is regulated by 
protein kinase C [4] and calmodulin-dependent processes 
[5], but is unaffected by cAMP [6,7]. 
There is evidence that certain amino acid transport 
systems are subject to adaptive regulation. In this type of 
regulation, cells can maintain their physiological and bio- 
chemical states by appropriately modulating the rate of 
transport across the plasma membrane when subjected to 
changing amino acid concentrations. The mechanism in- 
volved in the process may be either up- or down-regulation 
of the plasma membrane transport in response to changing 
states in amino acid availability. Examples of amino acid 
transport systems which are regulated in this manner in- 
clude systems A [8,9], L [10], XA6 [11], and N m [12]. 
Animal studies have shown that the taurine transporter 
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expressed in the kidney is also subject o adaptive regula- 
tion [13-15]. Recently, the modulation of the taurine trans- 
porter activity by the availability of taurine has been 
demonstrated in cultured cell lines of renal origin [16,17]. 
The ability of the kidneys to conserve taurine in women 
undergoes significant changes during pregnancy and lacta- 
tion [18]. There is a need for the mother to conserve this 
amino acid during these reproductive stages because of the 
increased emands. Fetal tissues accumulate large quanti- 
ties of taurine which has to be obtained solely from the 
mother because fetal tissues, including the placenta, have 
no or only negligible capacity to synthesize the amino acid 
[19,20]. Human milk contains high levels of taurine and 
the secretion of taurine in milk causes increased emands 
for this amino acid in lactating women. Accordingly, the 
ability of the kidney to reabsorb taurine increases ignifi- 
cantly both during pregnancy and lactation as a physio- 
logical response to meet the needs of the developing fetus 
and the suckling infant for this amino acid. Whether the 
placenta is also capable of regulating its taurine transport 
capacity in response to taurine availability in the mother 
has not been investigated. Since transplacental transfer of 
taurine is an obligatory step in satisfying the fetal demands 
for this amino acid, it is very likely that the placenta offers 
an additional site of regulation to ensure optimal taurine 
nutrition in the developing fetus. The present study was 
undertaken to investigate the adaptive regulation of the 
human placental taurine transporter using the JAR human 
placental choriocarcinoma cell line as an experimental 
model. 
2. Materials and methods 
2.2. Methods 
Culture of JAR human placental choriocarcinoma cells 
The JAR cells were cultured in 75 cm 2 culture flasks 
using RPMI-1640 medium supplemented with 10% fetal 
bovine serum, penicillin (100 units/ml) and streptomycin 
(100 /zg/ml). Cultures were maintained at 37°C in an 
atmosphere of 95% air/5% CO 2 till they reached conflu- 
ence. Subcultures were started from the cells released by 
trypsin treatment. The cells were seeded in 35 mm Petri 
dishes at a density of 1.5.106 cells/dish and allowed to 
grow for 24 h in the culture medium which contained 5% 
fetal bovine serum. Following this, the medium was re- 
moved and the cells were allowed to grow for an addi- 
tional 24 h (for varying time in one experiment) in a 
hormonally defined medium in the absence of serum. The 
defined medium [21] was made up of RPMI-1640 medium 
containing penicillin (100 units/ml), streptomycin (100 
/~g/ml), insulin (5 /zg/ml), apotransferrin (5 /~g/ml), 
prostaglandin Ej (2.5.10 -5 M), hydrocortisone (5.10 -8 
M) and thyroxine (5 • 10 -12 M). Stock solutions of prosta- 
glandin E 1, hydrocortisone and thyroxine were prepared in 
dimethylsulfoxide. The final concentration f dimethylsulf- 
oxide in the defined medium was 0.125%. The amino acid 
substrates used to study the adaptive response were added 
to the defined medium. Thus, the cells were exposed to 
these substrates for 24 h prior to uptake measurement. 
When the involvement of RNA and protein synthesis in 
the adaptive response was studied, actinomycin D (0.02 
/xg/ml) or cycloheximide (25/xM), dissolved in dimethyl- 
sulfoxide, was added to the defined medium. In these 
experiments, the final concentration of dimethylsulfoxide 
in the medium was 0.335%. 
2.1. Materials 
The JAR human placental choriocarcinoma cell line 
was obtained from the American Type Culture Collection 
(Rockville, MD, USA). RPMI-1640 medium, penicillin 
and streptomycin were purchased from Life Technologies 
(Gaithersburg, MD, USA). Fetal bovine serum was from 
Atlanta Biologicals (Atlanta, GA, USA). Amino acids, 
insulin, prostaglandin E 1, apotransferrin, hydrocortisone, 
thyroxine, cycloheximide and actinomycin D were ob- 
tained from Sigma (St. Louis, MO, USA). Guanidino- 
ethanesulfonic a id was a gift from Prof. T. Hoshi, Univer- 
sity of Shizuoka, Shizuoka, Japan. 
[2-3H]Taurine (spec. radioactivity, 21.9 Ci/mmol), /3- 
[3-3H]alanine (spec. radioactivity, 92.6 Ci/mmol), L-[4,5- 
3H]leucine (spec. radioactivity, 60 Ci/mmol) L-[3- 
3H]alanine (spec. radioactivity, 76.9 Ci/mmol), and 5- 
[1,2- 3H]hydroxytryptamine (serotonin) (spec. radioactivity, 
26.4 Ci/mmol) were purchased from DuPont-New Eng- 
land Nuclear (Boston, MA, USA). [5,6-3H]Uridine (spec. 
radioactivity, 30 Ci/mmol) was purchased from American 
Radiolabeled Chemicals (St. Louis, MO, USA). 
Uptake measurement 
Confluent monolayer cultures were used for uptake 
measurements. All the steps in uptake measurements were 
carried out at room temperature. Briefly, the medium was 
aspirated and the monolayer was washed once with the 
uptake buffer. Fresh uptake buffer (1 ml) containing the 
radiolabeled compounds (taurine, /3-alanine, a-alanine, 
leucine or serotonin) was added to the dish and incubated 
for 3 min. Uptake was terminated by aspirating the medium 
and subsequently washing the monolayer thrice with the 
uptake buffer. The cells were then lysed with 1 ml of 0.2 
M NaOH/I% SDS and the contents were transferred to a 
counting vial to determine radioactivity. The composition 
of the uptake buffer in most experiments was 25 mM 
Hepes/Tris (pH 7.5), 140 mM NaCI, 5.4 mM KCI, 1.8 
mM CaC12, 0.8 mM MgSO 4 and 5 mM glucose. 
Measurement of leucine and uridine incorporation into 
acid-insoluble fraction 
This was done as described previously [7]. Radiolabeled 
leucine (1 /zCi/dish) or uridine (0.25 /xCi/dish) was 
added directly to the culture medium bathing the monolay- 
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ers and incubation continued for 2 h at 37 ° C. Following 
this, the medium was removed by aspiration and the 
monolayers were washed four times with 10% trichloro- 
acetic acid and once with an ether/ethanol (1:3, v /v )  
mixture. The dishes were allowed to dry and the contents 
were dissolved in 1 ml of 0.2 M NaOH/ I% SDS and used 
for determination f radioactivity. 
A similar procedure was used to determine the fraction 
of leucine or a-alanine that was incorporated into cellular 
proteins under the incubation conditions employed for 
uptake measurements. 
Preparation of plasma membrane vesicles 
Isolation of plasma membrane vesicles from JAR cells 
was done as described previously [22]. The JAR cells were 
grown in 225 cm 2 culture flasks for 24 h in the presence of 
5% fetal bovine serum. Following this, the medium was 
replaced with the hormonally defined medium with or 
without aurine and the cells were grown for an additional 
24 h. At the end of this treatment, he culture flasks were 
kept on ice for 15 min and the medium was removed by 
aspiration. The cells were washed twice with ice-cold 
phosphate-buffered saline. The cells were then suspended 
in ice-cold 10 mM Tris-HC1 buffer (pH 7.5) containing 2
mM EGTA and 10 mM KF (25 ml/flask) and homoge- 
nized in an Ultra-Turrax tissuemizer. Stock solution (1 M) 
of MgC12 was added to the homogenate to give a final 
concentration of 12 mM MgCI 2 and the mixture was 
stirred at 4 ° C for 10 min. The suspension was centrifuged 
at 3000 X g for 15 min and the resulting supernatant was 
again centrifuged at 60000 X g for 30 min. The final 
pellet was rinsed with and suspended in 10 mM Hepes/Tris 
buffer (pH 7.5) containing 280 mM mannitol, 2 mM 
EGTA and 10 mM KF. The activity of alkaline phos- 
phatase, a marker enzyme for the plasma membrane, mea- 
sured with p-nitrophenyl phosphate as the substrate [23] 
was enriched 8 _+ 2-fold in the final membrane prepara- 
tions compared to the starting cell homogenate. 
Uptake measurement i  membrane vesicles 
This was done as detailed previously [1,24]. Briefly, 40 
/xl of membrane vesicle suspension (200 /~g membrane 
protein) was mixed with 160 /~1 of uptake buffer contain- 
ing radiolabeled taurine or serotonin and incubated for 
desired time at room temperature. Initial uptake rate and 
equilibrium uptake were determined using 15 s and 6 h 
incubation periods respectively. Uptake was terminated by 
the addition of 3 ml of ice-cold stop buffer followed by 
rapid filtration through a Millipore filter (DAWP type, 
0.65 /xm pore size). The filter retaining the membrane 
vesicles was washed with 3 X 5 ml of the stop buffer and 
the radioactivity associated with the filter was determined 
by liquid scintillation spectrometry. The uptake buffer was 
10 mM Hepes/Tris (pH 7.5) containing 140 mM NaC1 or 
140 mM KC1. The stop buffer was 5 mM Hepes/Tris (pH 
7.5) containing 160 mM KCI. 
Protein determination 
Protein was assayed for each experiment by using du- 
plicate dishes cultured concurrently and under conditions 
identical with those dishes used for uptake measurements. 
Deionized water (1 ml) was added to each dish. The dishes 
were frozen and thawed twice, after which the contents 
were suspended to form a homogenate by using a 1 ml 
syringe and 25-gauge needle. Protein concentration f the 
homogenate was determined by the method of Lowry et al. 
[25]. 
Isolation of poly(A) + RNA and Northern blot analysis 
Poly(A) + RNA was isolated from JAR cells which 
were treated for 24 h with or without 250 /.LM taurine in a 
defined medium. This was achieved using FastTrack 
mRNA isolation kit (Invitrogen, San Diego, CA, USA). 
Poly(A) + RNA was size-fractionated on a denaturing for- 
maldehyde-agarose g l and transferred to an activated 
nylon membrane (Hybond N +, Amersham, Arlington 
Heights, IL, USA). Following overnight prehybridization 
of the membrane at 42°C in 50% formamide, 10X 
Denhardt's solution, 5 X SSPE (1 x SSPE = 0.15 M NaCI, 
32 mM NaHzPO4, 1 mM Na 2 EDTA, pH 7.4), 2% SDS, 
and 100 /xg/ml freshly denatured and sheared salmon 
DNA, hybridization was initiated by the addition of the 
cDNA probe and continued at 42 ° C for 24 h. The blot was 
washed twice at 22°C in 2 x SSPE and 0.1% SDS, fol- 
lowed by a 1-h wash at 65°C in 0.1 X SSPE and 0.1% 
SDS, and exposed to autoradiographic film. The same blot 
was used for the Northern analysis of the taurine trans- 
porter mRNA and the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA. This was done by se- 
quential hybridization, stripping, and rehybridization with 
respective cDNA probes. Sizes of hybridizing RNAs are 
based on parallel electrophoresis of RNA standards. Quan- 
tification of transcript signals in autoradiograms was done 
with a dual wavelength scanner (Shimadzu, model CS- 
9OOO). 
The taurine transporter cDNA probe was a 705 bp 
fragment of the coding region of the human placental 
taurine transporter cDNA [3]. The GAPDH cDNA probe 
was a 0.78 kb fragment obtained from a human GAPDH 
clone (ATCC, Rockville, MD, USA) by digestion with 
PstI and XbaI. The cDNA probes were gel purified and 
radiolabeled with [c~-32p]dCTP (Amersham, Arlington 
Heights, IL, USA) by random priming. The labeled 
cDNAs were purified from free nucleotides by size-exclu- 
sion chromatography on a Sephadex G-50 column. 
Statistics and data analysis 
Each experiment was repeated 2-3 times with replicate 
dishes and the results are given as means _+ S.E. Kinetic 
analyses were carried out using the computer software Fig. 
P. version 6.0 (BioSoft, Cambridge, UK). The kinetic 
parameters, K t and Vma x, were calculated by linear regres- 
sion analysis (Eadie-Hofstee method). 
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3. Results 
3.1. Effects of exposure of JAR cells to taurine on the 
activity of the taurine transporter 
The JAR cells were exposed to varying concentrations 
(0-250 /zM) of taurine in a hormonally defined medium 
for 24 h. Following this treatment, he activity of the 
taurine transporter in these cells was measured by deter- 
mining the uptake rate of radiolabeled taurine. Exposure of 
the cells to taurine resulted in a marked decrease in the 
taurine transporter activity (Fig. 1). This adaptive response 
was dose-dependent. The decrease was 70-75% when the 
concentration of taurine during the exposure period was 
250 /.tM. 
Fig. 2 describes the time-dependence of the adaptive 
response. In this experiment, cells were exposed to 250 
/zM taurine for varying time, following which the medium 
was removed and the activity of the taurine transporter was 
determined by measuring the uptake of radiolabeled tau- 
rine. The transporter activity was found to decrease as the 
time of exposure of the cells to unlabeled taurine in- 
creased. The maximal decrease (~ 80%) was observed 
with an exposure time of 12 h. 
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Fig. 2. Time-dependence of the inhibition of the taurine transporter by 
treatment of the cells with taurine. Confluent monolayer cultures of JAR 
cells were treated with 250 /zM taurine for varying time periods in a 
hormonally defined medium at 37 ° C. After the treatment, he medium 
was removed and the monolayers were washed twice with the uptake 
buffer. The activity of the taurine transporter was determined by measur- 
ing the uptake of [3H]taurine (30 nM) using an incubation time of 3 min. 
Uptake in control cells which were not treated with taurine was 1.30 Jr 0.04 
pmol/3 min per mg of protein and this value was taken as 100%. The 
data represent means Jr S.E. from four determinations. 
3.2. Specificity of the adaptive response 
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Fig. 1. Dose-response relationship for the inhibition of the taurine 
transporter by treatment of cells with taurine. Confluent monolayer 
cultures of JAR cells were treated with varying concentrations of taurine 
(0-250/zM) in a hormonally defined medium for 24 h at 370 C. After the 
treatment, he medium was removed and the monolayers were washed 
twice with the uptake buffer. The activity of the taurine transporter was 
determined by measuring the uptake of [3H]taurine (30 nM) using an 
incubation time of 3 min. Uptake in control cells which were not treated 
with taurine was 1.51+0.09 pmol /3 min per mg of protein and this 
value was taken as 100%. The data represent means jrS.E, from four 
determinations. 
To determine which amino acids were capable of regu- 
lating the taurine transporter function, the cells were ex- 
posed to different amino acids for 24 h in a defined 
medium following which the activity of the taurine trans- 
porter was measured (Table 1). Taurine, hypotaurine, fl- 
alanine, and guanidinoethanesulfonic acid were able to 
Table 1 
Specificity of the substrate-dependent 
activity in JAR cells 
r gulation of the taurine transporter 
Test substrate Uptake (pmol/3 rain per mg of protein) 
taurine /3-alanine 
None 1.03 Jr 0.04 (100) 0.159 -t- 0.009 (100) 
Taurine 0.19 Jr 0.02 (19) 0.035 Jr 0.003 (22) 
Hypotaurine 0.21 + 0.04 (20) 0.033 Jr 0.002 (21) 
fl-Alanine 0.39 + 0.01 (38) 0.055 Jr 0.003 (35) 
GES 0.47 Jr 0.04 (46) 0.069 Jr 0.006 (43) 
AIB 1.04+0.05 (101) 0.157+0.009 ( 9) 
Betaine 1.15-t-0.05 (112) 0.179+0.005 (113) 
Confluent monolayer cultures of JAR cells were treated with or without 
different test substrates (250 /zM) in a hormonally defined culture 
medium for 24 h at 37 ° C. After the treatment, the medium was removed 
and the monolayers were washed with the uptake buffer. The activity of 
the taurine transporter was determined by measuring the uptake of 
[3H]taurine (30 nM) or/3-[3H]alanine (15 nM). The uptake buffer was 25 
mM Hepes/Tris (pH 7.5), 140 mM NaC1, 5.4 mM KCI, 1.8 mM CaCI 2, 
0.8 mM MgSO 4, and 5 mM glucose. The time of incubation for uptake 
measurements was 3 min. The values in parentheses are percent of uptake 
in control cells treated in the absence of test substrates. The data represent 
means + S.E. from four determinations. 
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decrease the activity of the transporter and the order of 
potency was taurine = hypotaurine > fl-alanine > 
guanidinoethanesulfonic acid. All four amino acids are 
substrates for the taurine transporter. The decrease in the 
activity of the taurine transporter was evident whether the 
activity was measured as taurine uptake or /3-alanine up- 
take. The inhibitory effects of taurine, hypotaurine, /3- 
alanine, and guanidinoethanesulfonic acid as well as the 
order of their potency were identical for the uptake of both 
taurine and /3-alanine. In contrast, AIB and betaine which 
are not substrates for the taurine transporter were unable to 
regulate the taurine transporter activity. Thus, the adaptive 
response of the taurine transporter in the JAR cells was 
specific towards the substrates of the transporter. 
We also studied the specificity of the response with 
respect o the transport system involved (Table 2). The 
JAR cells were treated in the presence or absence of 
taurine (250 /zM) for 24 h, following which the activities 
of four different transport systems were measured. The 
activity of the taurine transporter measured as the uptake 
of taurine decreased in an adaptive response to exposure to 
taurine. In contrast, the activities of the serotonin trans- 
porter (serotonin uptake) and the amino acid transport 
systems ASC (a-alanine uptake) and L (leucine uptake) 
remained unaltered. In these experiments, uptake of a- 
alanine and leucine was measured with a 3 min incubation. 
Under these conditions, the measured values represented 
predominantly transport. The fraction of the amino acid 
that was incorporated into proteins was found to be 1.3 + 
0.2% for a-alanine and 18.6 + 0.3% for leucine. However, 
since the value was a significant fraction of the measured 
uptake in the case of leucine, we have repeated the leucine 
uptake measurements in control and in taurine-exposed 
cells with a 1 min incubation. With this incubation period, 
the fraction of leucine that was incorporated into proteins 
was only 2.0 + 0.2%. There was again no difference in 
Table 2 
Influence of culturing the JAR cells in the presence of taurine on the 
activities of different ransport systems 
Transporter substrate Uptake (pmol/3 min per mg of protein) 
control taurine-treated 
Taurine 1.35 + 0.09 (100) 0.32 + 0.05 (24) 
Serotonin 0.46 _ 0.02 (100) 0.44 + 0.02 (96) 
a-Alanine 1.16+0.08 (100) 1.14+0.01 (98) 
Leucine 0.44 + 0.03 (100) 0.45 + 0.06 (103) 
Confluent monolayer cultures of JAR cells were treated with or without 
250 p,M taurine in a hormonally defined culture medium for 24 h at 
37 ° C. After the treatment, the medium was removed and the monolayers 
were washed twice with the uptake buffer. The activities of the taurine 
transporter, serotonin transporter, and amino acid transport systems ASC 
and L were determined by measuring the uptake of taurine (30 nM), 
serotonin (75 nM), a-alanine (10 nM) and leucine (5 nM), respectively. 
The time of incubation for uptake measurements was 3 min. The values 
in parentheses are percent of uptake in respective control cells treated in 
the absence of taurine. The data represent means + S.E. from four deter- 
minations 
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Fig. 3. Kinetic analysis of taurine uptake in control and taurine-treated 
cells. Confluent monolayer cultures of JAR cells were treated with (O) or 
without (0 )  taurine (250/xM) in a hormonally defined medium for 24 h 
at 37 ° C. After the treatment, the medium was removed and the monolay- 
ers were washed twice with the uptake buffer. The NaCl-dependent 
uptake of taurine was measured over a concentration range of 0.5-10 
/~M, using an incubation time of 3 min. Concentration of [3H]taurine was 
kept at 0.05 /~M and the final concentration of taurine was adjusted by 
adding appropriate amounts of unlabeled taurine. Uptake of radioactivity 
measured in the presence of an excess amount of unlabeled taurine (500 
p.M) was used to determine the nonmediated uptake at each concentration 
of taurine. This value was subtracted from total uptake to calculate the 
mediated uptake. The data represent means+S.E, from four determina- 
tions. 
leucine uptake between control and taurine-exposed cells, 
the values being 0.25 + 0.01 and 0.23 + 0.01 pmol/min 
per mg of protein respectively. Thus, the adaptive response 
to taurine exposure is specific for the taurine transporter. 
3.3. Kinetics of taurine uptake in control and taurine-ex- 
posed cells 
The dependence of the uptake rate on taurine concentra- 
tion was investigated in control and in taurine-exposed 
cells (Fig. 3). In both cases, the uptake rate was hyperboli- 
cally related to taurine concentration, suggesting participa- 
tion of a saturable transport system. Eadie-Hofstee plots 
(uptake rate/taurine concentration versus uptake rate) were 
linear (r 2 > 0.99) in control as well as in taurine-exposed 
cells (data not shown). The kinetic constants, K t (Michae- 
lis-Menten constant) and Vma x (maximal velocity), in con- 
trol cells were 4.9 _ 0.2 /zM and 329 + 10 pmol/3 min 
per mg of protein, respectively. The corresponding values 
in taurine-exposed cells were 6.7 + 0.4 /xM and 104 + 4 
pmol/3 min per mg of protein. Thus, the taurine-induced 
adaptive inhibition of the activity of the taurine transporter 
is associated with a decrease in the affinity of the trans- 
porter for this substrate and also with a decrease in the 
maximal velocity of the transporter. The effect on the 
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maximal velocity was however much greater than the 
effect on the affinity. 
3.4. Na +- and Cl--kinetics of the taurine transporter in 
control and taurine-treated cells 
The activity of the taurine transporter in JAR cells is 
dependent on Na + as well as e l -  [4]. This characteristic s 
also true in the case of the transporter expressed in the 
brush border membrane of the normal placenta [1,26]. 
Stoichiometric analysis has shown that 2 Na + and 1 Cl -  
are involved in the transport of one taurine molecule in 
placental brush border membrane vesicles [3,26,27]. The 
Na+/C1 /taurine stoichiometry has not been determined 
for the JAR cell taurine transporter. Since exposure of JAR 
cells leads to a decrease in the taurine transporter activity, 
it was of interest o determine whether this adaptive change 
was associated with alterations in the Na +-  and el- -de- 
pendence and kinetics. Therefore, we investigated the de- 
pendence of the taurine uptake rate on Na + concentration 
in the presence of a fixed concentration of C1 and on e l -  
concentration i  the presence of a fixed concentration of 
Na + in control cells and in taurine-exposed cells. The 
relationship between uptake rate and Na + concentration 
was found to be sigmoidal in control and in taurine-ex- 
posed cells (data not shown), indicating involvement of 
more than one Na + ion in the transport of one taurine 
molecule. The experimental data were fit into the Hill-type 
equation 
V M • [Na + ]" 
U= 
K~.5 + [Na + ]" 
where v is the uptake rate, V M is the uptake rate at infinite 
concentration of Na +, K0. 5 is the concentration of Na + 
necessary to give an uptake rate equal to 0.5 × V M and n 
is the number of Na + ions involved per transport cycle. 
Nonlinear regression analysis of the data according to this 
equation gave a value of 2.1 _+ 0.2 for n and 68 _+ 4 mM 
for K0. 5 in control cells. The corresponding values in 
taurine-exposed cells were 1.8 -4- 0.1 and 65 _+ 3 mM. These 
results show that the number of Na + ions involved in the 
transport cycle and the affinity of the transporter for Na + 
(as indicated by K0. 5) remain unaltered after exposure to 
taurine. 
Similar experiments on the dependence of the taurine 
transporter activity on e l -  concentration revealed that the 
relationship was hyperbolic in control and in taurine-treated 
cells (data not shown). This suggests that one C1- ion is 
involved in the transport of one taurine molecule in both 
cases. The value for K0. 5 for CI-  was 51 +_ 14 mM in 
control cells and 36 ± 11 mM in taurine-treated cells. 
Thus, the number of e l -  ions involved in the transport 
process and the affinity of the transporter for e l -  were not 
affected by taurine exposure. 
The procedure used here to determine the Na+/taurine 
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Fig. 4. Time-course of taurine uptake in plasma membrane v sicles (A) 
and in intact cells (B). Confluent cultures of JAR cells were treated with 
(O) or without (O) 250 /xM taurine in a hormonally defined culture 
medium for 24 h at 37 ° C. After treatment, the medium was removed by 
aspiration and the monolayers were rinsed twice with a taurine-free 
medium. The cells were then either used directly for uptake measure- 
ments or used for preparation f plasma membrane v sicles. Uptake in 
membrane v sicles was measured in the presence ofan inwardly directed 
NaCI gradient at a taurine concentration of 0.2/zM. Uptake in intact cells 
was measured in the presence of NaC1 in the medium at a taurine 
concentration f 30 nM. The data represent means+S.E, from four 
determinations. 
and C1-/taurine coupling ratios is called 'activation' 
method [28]. This approach has been widely used to 
determine stoichiometric relationships for various ion-cou- 
pled transport systems. However, it has to be mentioned 
that what is measured in this approach is the dose-response 
relationship for the ability of the coupling ions to activate 
the transport of the substrate. The actual transport of the 
ions which is coupled to the transport of the substrate is 
not measured. Since the validity of this method depends on 
the mechanism involved in the activation process, this can 
be considered at best only an indirect approach to deter- 
mine the stoichiometry. 
3.5. Uptake of taurine and serotonin in plasma membrane 
vesicles prepared from control and taurine-exposed cells 
To determine whether the substrate-specific adaptive 
regulation of the taurine transporter activity observed in 
intact cells can be shown at the level of the plasma 
membrane, control cells and taurine-exposed cells were 
lysed and used for isolation of plasma membrane vesicles. 
Uptake of taurine was measured in these membrane prepa- 
rations in the presence of an inwardly directed NaCI 
gradient (Fig. 4A). The uptake was linear at least up to 30 
s in membrane vesicles prepared from control as well as 
taurine-exposed cells. The initial uptake rate measured 
with a 15 s incubation was 55% less in membrane vesicles 
from taurine-exposed cells than from control cells. This 
decrease in the uptake was not due to alterations in the 
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vesicle volume as evident from the findings that there was 
no difference in the equilibrium uptake (6 h incubation) 
between these two membrane preparations. The uptake 
measured with shorter incubations was many-fold greater 
than the uptake measured with a 6 h incubation in both 
membrane preparations, demonstrating a transient uphill 
transport of taurine in response to the transmembrane NaCI 
gradient. For comparison, the time-course of taurine up- 
take in intact cells is given in Fig. 4B. The uptake was 
linear in control as well as in taurine-exposed cells for at 
least upto 6 rain. The uptake was 75% less in control cells 
compared to taurine-exposed cells at all time periods mea- 
sured. 
A possible explanation for the observed changes in the 
taurine transport activity in plasma membrane vesicles 
isolated from control versus taurine-exposed cells may be 
that the plasma membrane permeability for Na ÷ and C1- 
increases as a result of exposure of the cells to taurine. We 
tested this possibility by measuring the activity of the 
serotonin transporter in these membrane vesicles under 
identical conditions. The taurine transporter as well as the 
serotonin transporter belong to the Na ÷- and O--coupled 
transporter family. Any change in the Na ÷- and C1--per- 
meabilities of the plasma membrane is expected to affect 
the activity of the serotonin transporter as well. The uptake 
of serotonin (0.2 /xM) measured in plasma membrane 
vesicles derived from control cells was 1.11 +0.03 
pmol/15 s per mg of protein. The corresponding value in 
plasma membrane vesicles derived from taurine-exposed 
cells was 1.21 + 0.08 pmol/15 s per mg of protein. The 
lack of effect of taurine exposure on the activity of the 
serotonin transporter suggests that the membrane perme- 
abilities for Na ÷ and C1- remain unaltered uring expo- 
sure of the cells to taurine. Therefore, the observed e- 
crease in taurine transport in membrane vesicles from 
taurine-exposed cells versus control cells cannot be due to 
alterations in the Na ÷- and Cl--permeability characteristics 
of the plasma membrane resulting from exposure to tau- 
fine. 
3.6. Effects of inhibitors of protein and RNA synthesis on 
the taurine-induced adaptive regulation of the taurine 
transporter 
To evaluate the role of synthesis of the taurine trans- 
porter protein in the adaptive regulation of the transporter 
activity, the cells were treated with or without taurine in 
the presence or absence of cycloheximide, an inhibitor of 
protein synthesis, and actinomycin D, an inhibitor of RNA 
synthesis. Uptake of taurine was subsequently measured in 
these cells (Table 3). In the absence of inhibitors, exposure 
to taurine caused a 72% decrease in the transporter activ- 
ity. This decrease could be blocked to a significant extent, 
but not completely, when the cells were treated with 
taurine in the presence of inhibitors of RNA and protein 
synthesis. The taurine-induced decrease in the transporter 
Table 3 
Effects of cycloheximide and actinomycin D on substrate-dependent 
regulation ofthe taurine transporter activity in JAR cells 
Treatment Uptake of taurine 
(pmol/3 min per cm 2) 
None 0.251 ± 0.003 (100) 
Taurine 0.069 + 0.003 (28) 
Cycloheximide 0.156 + 0.001 (100) 
Cycloheximide + taurine 0.096 ± 0.003 (62) 
Actinomycin D 0.135 + 0.003 (100) 
Actinomycin D + taurine 0.059 + 0.001 (44) 
Confluent monolayer cultures of JAR cells were treated with or without 
taurine (250 /xM) in the absence orpresence ofcycloheximide (25 /xM) 
or actinomycin D (0.02 /~g/ml) in a hormonally defined culture medium 
for 16 h at 37 ° C. After the treatment, the medium was removed and the 
monolayers were washed twice with the uptake buffer. The activity of the 
taurine transporter was determined bymeasuring the uptake of [3 H]taurine 
(30 nM) by using an incubation period of 3 min. The values in parenthe- 
ses are percent of uptake in respective control cells treated inthe absence 
of taurine. The data represent means +S.E. from six determinations 
activity was 38% in the presence of cycloheximide and 
56% in the presence of actinomycin D. That cyclohex- 
imide was able to block protein synthesis under the experi- 
mental conditions employed was clearly evident from a 
97% decrease as the result of cycloheximide treatment in 
the incorporation of leucine into acid-insoluble fraction 
(data not shown). Similarly, actinomycin D was very 
effective in blocking RNA synthesis and, as a result, in 
protein synthesis. Treatment of the cells with actinomycin 
D decreased the incorporation of uridine into acid-insolu- 
ble fraction by 97%. The actinomycin D-induced ecrease 
in incorporation of leucine was 90% (data not shown). 
3. 7. Steady state levels of taurine transporter mRNA in 
control and taurine-exposed cells 
To determine whether alterations in the steady state 
levels of the taurine transporter mRNA play a role in the 
taurine-induced adaptive regulation of the taurine trans- 
porter activity, we estimated the levels of the taurine 
transporter mRNA in control and taurine-exposed cells. 
These cells possess multiple forms of the transporter mRNA 
and a 6.9 kb transcript is the most predominant among 
these forms. The levels of this transcript decreased by 67% 
in taurine-exposed cells compared to control cells (Fig. 5). 
In these experiments, the levels of the GAPDH mRNA 
were also analyzed as an internal control for RNA loading 
and transfer efficiency. The taurine transporter 
mRNA/GAPDH mRNA ratio was 1.59 in control cells. 
This ratio decreased by 65% to 0.56 in taurine-exposed 
cells. In these experiments, cells which were exposed to 
AIB served as negative control. Exposure of the cells to 
AIB did not alter the taurine transport activity and accord- 
ingly there was no noticeable change in the steady state 
levels of the 6.9 kb transcript. These experiments were 
repeated three times and the decrease in the taurine trans- 
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Fig. 5. Northern blot analysis. Confluent monolayer cultures of JAR cells 
were treated with 250 ~M taurine, 250 /xM AIB or without these animo 
acids in a hormonally defined medium for 24 h at 37 ° C. After the 
treatment, poly(A) ÷ RNA was isolated from the cells. The size- 
fractionated mRNA (lane 1, control cells; lane 2, taurine-exposed c lls; 
lane 3, AIB-exposed cells) was probed with the human placental taurine 
transporter DNA. The lower panel shows the corresponding Northern 
blot analysis of GAPDH mRNA. The same membrane blot which was 
used for the analysis of the taurine transporter mRNA was used to 
analyze the GAPDH mRNA. This was done by stripping the membrane 
off radioactivity and rehybridizing with the human GAPDH eDNA probe. 
porter mRNA levels as the result of exposure of the cells 
to taurine ranged between 35 and 65% with a mean value 
of 51%. 
4. Discussion 
The present study shows that exposure of the JAR 
placental choriocarcinoma cells to taurine down regulates 
the activity of the taurine transporter. This effect is very 
specific for the substrates of the transporter. This absolute 
substrate specificity is interesting because a strict correla- 
tion between substrate specificity and ability to induce 
adaptive response has not been observed in the case of the 
amino acid transport systems L [10], A [29,30] and XA~ 
[11]. Though the adaptive regulation of the taurine trans- 
porter has been studied previously in renal cell lines 
[16,17], the substrate specificity of the phenomenon has 
not been investigated. The results of the present study 
showing that the ability to induce adaptive response in the 
activity of the taurine transporter is not unique to taurine 
alone but is in fact shared by the other substrates of the 
transporter are of importance because these results are 
relevant o the understanding of the cellular mechanisms 
which underlie this adaptive regulation. A similar strict 
correlation between substrate specificity and ability to 
induce adaptive response has been recently observed in the 
case of the amino acid transport system N m [12]. In 
addition, as observed in the present study, the adaptive 
response induced by the substrates of system N m is spe- 
cific to this transport system with no change in the activi- 
ties of other transport systems. 
The present study provides detailed information on the 
kinetic characteristics of the taurine transporter in control 
cells and in taurine-exposed cells. In both cases, the basic 
properties of the transporter such as dependence of the 
transporter activity on Na + and C1- and the Na+/  
C1-/taurine stoichiometry for the transport process remain 
the same. Similarly, there is no detectable change in the 
affinities of the transporter for Na + and CI-. The decrease 
in the transporter activity caused by exposure to taurine is 
primarily associated with a decrease in the maximal veloc- 
ity and, to a lesser extent, with a decrease in the affinity of 
the transporter for taurine. This change in the affinity as a 
contributory factor in adaptive regulation is unique to the 
taurine transporter because the other transport systems 
which are subject o adaptive regulation such as the amino 
acid transport systems L, A, X~,~, and N m exhibit no 
change in K t in association with adaptive response [8-12]. 
The experiments with the inhibitors of RNA and protein 
synthesis show that the increase in the activity of the 
taurine transporter as a result of exposure of the JAR cells 
to the taurine-free culture medium is significantly blunted 
by cycloheximide and actinomycin D. This suggests that 
synthesis of new taurine transporter protein (or other possi- 
ble regulatory proteins) may be involved in the process. 
This is supported by the increase in the Vma x as well as in 
the steady state levels of the taurine transporter mRNA as 
a result of taurine deprivation. However, synthesis of new 
transporter protein alone is insufficient to explain the 
observed effects. The activity of the taurine transporter 
increases 3 to 4-fold in taurine-deprived cells compared to 
taurine-exposed cells. In contrast, this process is accompa- 
nied by only a 2-fold increase in the taurine transporter 
mRNA levels. Therefore, it is likely that other processes 
such as synthesis of regulatory proteins and/or posttrans- 
lational modification of the taurine transporter protein are 
involved in the adaptive regulation of the taurine trans- 
porter. 
To our knowledge, there has been only one report 
which describes the changes in transporter-specific mRNA 
levels in association with adaptive regulation of an amino 
acid transporter system [11]. In this case however, the 
increase in the activity of the transport system Xgc as a 
result of amino acid starvation is accompanied by an initial 
decrease in the transporter mRNA levels followed by a 
later restoration to control levels. It therefore appears that 
posttranscriptional events are principally responsible for 
adaptive regulation in the case of system XA~. In contrast, 
taurine deprivation in JAR cells leads to a significant 
increase in the transporter mRNA levels which is at least 
partly responsible for the increase in the transporter activ- 
ity observed under these conditions. 
When there is a decrease in the activity of a transporter 
in intact cells as a result of exposure to the substrates of 
the transporter, it can be argued that the decrease in the 
activity is due to the higher intracellular concentration of 
the substrates in the substrate-exposed cells compared to 
control cells. However, the results of the present study 
with purified plasma membrane vesicles do not support 
this argument. The change in the taurine transporter activ- 
ity observed in intact cells as a consequence of exposure to 
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taurine is observable even at the level of plasma membrane 
vesicles. The changes een in the taurine transporter activ- 
ity in membrane vesicles are not due to taurine-induced 
alterations in Na ÷- and C1--permeability characteristics of 
the plasma membrane because the activity of the serotonin 
transporter, which is also a Na ÷- and C1--coupled trans- 
port system, remains unaltered under similar conditions. 
Interestingly, the change in the activity of the transporter 
in plasma membrane vesicles is significantly less than the 
change in intact cells. The activity in taurine-exposed cells 
is 25-30% of the activity in control cells when the activity 
is measured in intact cells. However, when plasma mem- 
brane vesicles purified from these cells are used to deter- 
mine the transporter activity, the corresponding value is 
only 45%. If posttranslational modification of the trans- 
porter protein such as phosphorylation/dephosphorylation 
is at least partly responsible for the adaptive regulation, 
these covalent changes in the protein may be reversed to 
some extent during the membrane isolation procedure. 
This might explain the observed quantitative difference 
between intact cells and plasma membrane vesicles in the 
decline of the taurine transporter activity as a result of 
exposure of the cells to taurine. The time-dependence of 
the adaptive response showing that the taurine transport 
activity is decreased significantly even when the cells are 
exposed to taurine for a period as short as 1 h supports the 
notion that acute effects uch as posttranslational modifica- 
tion may be involved in this process. However, possible 
contribution of trans-inhibition of the taurine transporter 
by intracellular taurine to the observed ifference between 
intact cells and plasma membrane vesicles cannot be en- 
tirely ruled out. 
The cellular mechanisms which underlie the adaptive 
regulation of the activity of the taurine transporter in JAR 
cells are not known. In the case of the amino acid transport 
system L, it appears that the concentration of charged 
tRNA L~u molecules erves as the signal for inducing adap- 
tive regulation in response to leucine availability [31,32]. 
The substrates of the taurine transporter, in contrast, are 
not incorporated into proteins and there are no specific 
tRNAs for these amino acids. It has been suggested that 
accumulation of taurine inside the cells during exposure to 
taurine might modulate protein phosphorylation a d thereby 
affect taurine transport [17]. In fact, there is evidence that 
taurine is indeed capable of inhibiting phosphorylation f 
specific proteins in a variety of tissues [33]. But the present 
study indicates that the ability to induce adaptive response 
in the activity of the taurine transporter is by no means 
unique to taurine. This characteristic is shared by the other 
substrates of the transporter as well. It is however not 
known whether these other substrates also have the ability 
to inhibit protein phosphorylation, but it seems very un- 
likely. It therefore appears that some other cellular mecha- 
nisms must be involved in this phenomenon. The JAR cell 
taurine transporter is highly active and its concentrative 
capacity is remarkable. When these cells are exposed to 
the substrates of the taurine transporter for 24 h, these 
substrates are expected to be accumulated inside the cell to 
very high levels resulting in a significant change in the 
osmolality of the intracellular milieu. This change, with 
the accompanying alterations in the cell volume, might 
trigger cellular esponses including changes in intracellular 
Ca 2÷ levels [34] which might play a role in the modulation 
of transcriptional swell as posttranscriptional processes. 
The relevance of the findings presented here with cul- 
tured cells to the process of taurine transport from mother 
to fetus across the normal placenta is not known. It is 
likely that the placenta lso possesses the ability to regu- 
late the function of the taurine transporter in response to 
the concentration of taurine in the maternal circulation. 
This would enable the placenta to maintain optimal taurine 
nutrition in the developing fetus. In view of the accumulat- 
ing evidence for a crucial role of taurine in development 
[33,35], it is obvious that regulation of the placental trans- 
port of this amino acid is of physiologic significance. 
Acknowledgements 
This work was supported by the National Institutes of 
Health Grant HD 24451 and by a grant from Taisho 
Pharmaceutical Company. The authors acknowledge the 
expert secretarial ssistance of Joyce Hobson. 
References 
[1] Miyamoto, Y., Balkovetz, D.F., Leibach, F.H., Mahesh, V.B. and 
Ganapathy, V. (1988) FEBS Lett. 231,263-267. 
[2] Karl, P.I. and Fischer, S.E. (1990) Am. J. Physiol. 258, C443-C451. 
[3] Ramamoorthy, S., Leibach, F.H., Mahesh, V.B., Han, H., Yang-Feng, 
T., Blakely, R.D. and Ganapathy, V, (1993) Biochem. J. 300, 
893-900. 
[4] Kulanthaivel, P., Cool, D.R., Ramamoorthy, S., Mahesh, V.B., 
Leibach, F.H. and Ganapathy, V. (1991) Biochem. J. 277, 53-58. 
[5] Ramamoorthy, S., Leibach, F.H., Mahesh, V.B. and Ganapathy, V. 
(1992) Pediatr. Res. 32, 125-127. 
[6] Cool, D.R., Leibach, F.H., Bhalla, V.K., Mahesh, V.B. and Ganapa- 
thy, V. (1991) J. Biol. Chem. 266, 15750-15757. 
[7] Ramamoorthy, S., Cool, D.R., Mahesh, V.B., Leibach, F.H., Me- 
likian, H.E., Blakely, R.D. and Ganapathy, V. (1993) J. Biol. Chem. 
268, 21626-21631. 
[8] Kilberg, M.S. (1986) Fed. Proc. 45, 2438-2454. 
[9] Saier, M.H., Daniels, G.A., Boerner, P. and Lin, J. (1988) J. Membr. 
Biol. 104, 1-10. 
[10] Moreno, A., Lobaton, C.D. and Oxender, D.L. (1985) Biochim. 
Biophys. Acta 819, 271-274. 
[11] Plakidou-Dymock, S. and McGiven, J.D. (1993) Biochem. J. 295, 
749-755. 
[12] Tadros, L.B., Willhoft, N.M., Taylor, P.M. and Rennie, M.J. (1993) 
Am. J. Physiol. 265, E935-E942. 
[13] Chesney, R.W., Gusowski, N. and Friedman, A.L. (1983) Kidney 
Int. 24, 588-594. 
[14] Rozen, R. and Scriver, C.R. (1982) Proc. Natl. Acad. Sci (USA) 79, 
2101-2105 
[15] Park, T., Rogers, Q.R., Morris, J.G. and Chesney, R.W. (1989) J. 
Nutr. 119, 1452-1460. 
360 L.D. Jayanthi et al. / Biochimica et Biophysica Acta 1235 (1995) 351-360 
[16] Jones, D.P., Miller, L.A. and Chesney, R.W. (1990) Kidney Int. 38, 
219-226. 
[17] Jones, D.P., Miller, L.A., Dowling, C. and Chesney, R.W. (1991) J. 
Am. Soc. Nephrol. 2, 1021-1029. 
[18] Naismith, D.J., Rana, S.K. and Emery, P.W. (1986) Hum. Nutr. 
Clin. Nutr. 40C, 37-45. 
[19] Sturman, J.A., Gaull, G. and Raiha, N.C.R. (1970) Science 169, 
74-76 
[20] Gaull, G., Sturman, J.A. and Raiha, N.C.R. (1972) Pediatr. Res. 6, 
538-547. 
[21] Taub, M., Chuman, L., Saier, M.H. and Sato, G. (1979) Proc. Natl. 
Acad. Sci. USA 76, 3338-3342. 
[22] Jayanthi, L.D., Ramamoorthy, S., Mahesh, V.B., Leibach, F.H. and 
Ganapathy, V. (1994) J. Biol. Chem. 269, 14424-14429. 
[23] Forstner, G.G., Sebesin, S.M. and lsselbacher, K.J. (1968) Biochem. 
J. 106, 381-390. 
[24] Balkovetz, D.F., Tiruppathi, C., Leibach, F.H., Mahesh, V.B. and 
Ganapathy, V. (1989) J. Biol. Chem. 264, 2195-2198. 
[25] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) 
J. Biol. Chem. 193, 265-275. 
[26] Moyer, M.S., Insler, N. and Dumaswala, R. (1992) Biochim. Bio- 
phys. Acta 1109, 74-80. 
[27] Kulanthaivel, P. Leibach, F.H., Mahesh, V.B. and Ganapathy, V. 
(1989) Biochim. Biophys. Acta 985, 139-146. 
[28] Turner, R.J. (1983) J. Membr. Biol. 76, 1-15. 
[29] Handlogten, M.E., Kilberg, M.S. and Christensen, H.N. (1982) J. 
Biol. Chem. 257, 345-348. 
[30] Felipe, A., Soler, C. and McGiven, J.D. (1992) Biochem. J. 284, 
577-582. 
[31] Moore, P.A., Jayme, D.W. and Oxender, D.L. (1977) J. Biol. Chem. 
252, 7427-7430. 
[32] Shotwell, M.A., Mattes, P.M., Jayme, D.W. and Oxender, D.L. 
(1982) J. Biol. Chem. 257, 2974-2980. 
[33] Huxtable, R.J. (1992) Physiol. Rev. 72, 101-163. 
[34] Haussinger, D. and Lang, F. (1991) Biochim. Biophys. Acta 1071, 
331-350. 
[35] Sturman, J.A. (1993) Physiol. Rev. 73, 119-147. 
